Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Immunic, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 54 | −10 |
| Shares | 20.2M | 500 | 18.4M | −1.83M (−9.1%) |
| Value | $50.7M | $1.00K | $27.0M | −$23.7M (−46.7%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Immunic, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 190,854 | $280.6K | 0.00% |
| American Century Companies Inc | 20,942 | $30.8K | 0.00% |
| Buck Wealth Strategies, LLC | 450 | $662 | 0.00% |
| Qube Research & Technologies Ltd | 58 | $85 | 0.00% |
Sold out (14)
Institutions that held Immunic, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Vivo Capital, LLC | 632,184 | $1.59M |
| Deep Track Capital, LP | 308,314 | $773.9K |
| Virtu Financial LLC | 67,424 | $169.0K |
| Simplex Trading, LLC | 42,728 | $107.0K |
| Wolverine Trading, LLC | 18,150 | $41.7K |
| Two Sigma Securities, LLC | 14,346 | $36.0K |
| Jane Street Group, LLC | 13,157 | $33.0K |
| HRT Financial LP | 12,648 | $31.0K |
| Cubist Systematic Strategies, LLC | 11,091 | $27.8K |
| Vontobel Holding Ltd. | 10,000 | $25.1K |
| Baader Bank INC | 11,262 | $21.9K |
| Citadel Advisors LLC | 1,879 | $4.72K |
| Adirondack Retirement Specialists, Inc. | 2 | $5 |
| IFP Advisors, Inc | 2,000 | – |
Not filed for Q3 2023 yet (1)
Institutions that held Immunic, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Endurance Wealth Management, Inc. | 500 | $1.00K |